Microvention Inc 35 Enterprisealiso Viejo Ca 92656 Pma Numberp170013 Supplement Numbers009 Date Received06 10 2022 Decision Date06 28 2022 Product Code Qca Advisory Committee Neurology Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Microvention Inc 35 Enterprisealiso Viejo Ca 92656 Pma Numberp170013 Supplement Numbers009 Date Received06 10 2022 Decision Date06 28 2022 Product Code Qca Advisory Committee Neurology Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P170013S009 MicroVention, Inc.35 Enterprisealiso Viejo, CA 92656 PMA NumberP170013 Supplement NumberS009 Date Received06/10/2022 Decision Date06/28/2022 Product Code QCA  Advisory Committee Neurology Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted? No	Low-Profile Visualized Intraluminal Support (LVIS) and LVIS Jr. X	2022-06-28